Dark

MDWD
MediWound Ltd
stock NASDAQ

At Close

10/5/2022 3:59:33 PM EDT

1.46USD-2.667%(-0.04)197,630

1.41Bid 1.46Ask 0.05Spread IEX

Pre-market

1969-12-31

0.00USD-100.000%(-1.50)0

After-hours

1969-12-31

0.00USD0.000%(0.00)0

Overview Option Chain HistoricalMore

open chart

Market Cap

48.385M

Headquarters

42 Hayarkon Street, Yavne, Israel

Industry

Biotechnology

Next Earnings

2022-11-15 (40d)

BSTC JNJ SNN TARO TEVA XLV

MDWD Stats

Avg. Vol. 10 Day

99,187

Avg. Vol. 30 Day

121,357

Employees

Market Cap

48,385,324

Shares Out.

33,140,633

Float

22,665,455

P/E Ratio

-3.13

EPS (ttm)

-0.531

On/Off Exchange

60%/40%

6 Month Beta

0.65

1 Year Beta

0.59

2 Year Beta

0.67

3 Year Beta

0.69

52 Week Low

1.21

52 Week High

4.01

SMA50

1.82

SMA200

1.85

1 Week

+5.04%

1 Month

-21.93%

3 Month

-21.08%

6 Month

-28.43%

1 Year

-52.90%

2 Year

-61.07%

5 Year

-71.37%

Jan 24, 2022

07:13AM EST MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers Benzinga

06:06AM EST MediWound Announces Positive Topline Results From U.S. Phase 2 Trial Of EscharEx For Debridement Of Chronic Wounds RTTNews

06:03AM EST MediWound Announces Topline Results From Its U.S. Phase 2 Trial Of EscharEx For Debridement Of Chronic Wounds; Co. Reports Primary Endpoint Met With Highly Statistically Significant Results Along With No Observed Safety Issues Benzinga

06:00AM EST Primary Endpoint Met with Highly Statistically Significant ResultsNo Observed Safety IssuesFinal Data Readout Expected in Second Quarter of 2022 GlobeNewswire Inc

Jan 5, 2022

11:16AM EST MediWound Granted European Patent Titled 'DEBRIDING COMPOSITION FOR TREATING WOUNDS' Benzinga

More News

Profile

MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Its strategy is centered around its validated enzymatic platform technology, focused on next-generation bio-active therapies for burn and wound care and biological medicinal products for tissue repair.

MDWD Stock Summary

MediWound Ltd (NASDAQ:MDWD) stock price today is $1.46, and today's volume is 197,630. MDWD is down -2.667% today. The 30 day average volume is 121,357. MDWD market cap is 48.385M with 33,140,633 shares outstanding.

document.getElementById("bNM12L").onerror = function(){this.style.display='none';}; .dark-mode .GzLHjM{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .GzLHjM{ color: #333333; background-color: white; border: 2px solid #333333; }MDWDMediWound Ltdstock NASDAQ

MDWD Stock Summary

MDWD
MediWound Ltd
stock NASDAQ